The physician-scientists at Lurie Children’s Hospital develop and participate in innovative research to offer new treatments, improve the standard of care and increase knowledge about the biology of brain and spinal cord tumors. Lurie Children’s offers more than 25 local and national clinical trials for patients with brain and spinal cord tumors.
The CBTTC is a collaborative, multi-institutional research program dedicated to the study and treatment of childhood brain tumors. The CBTTC consists of 16 primary member institutions such as Children’s Hospital of Philadelphia, Seattle Children’s, Ann & Robert H. Lurie Children’s Hospital of Chicago, Benioff Children’s Hospital (UCSF), Stanford University/Lucile Packard Children’s Hospital, Meyer Children’s Hospital Florence Italy, Children’s National Health System, The Beijing Tiantan Hospital Neurosurgery Center (Beijing, China) and The Hudson Institute of Medical Research (Melbourne, Australia). The CBTTC is transforming cancer research by using data to discover better treatments and cures for children diagnosed with pediatric brain tumors. At each of the Children's Brain Tumor Tissue Consortium's member institutions, breakthroughs are made possible through the teamwork and collaboration of doctors, researchers and patients.